Boxed warnings (formerly known as Black Box Warnings) are the highest safety-related warning that medications can have assigned by the Food and Drug Administration. These warnings are intended to bring the consumer’s attention to the major risks of the drug. Medications can have a boxed warning added, taken away or updated throughout its tenure on the market. Over 400 different medications currently have boxed warnings.
Boxed warnings typically apply to a particular drug cohort rather than one specific drug; this is because usually the severe risk is associated with the mechanism of action and its undesired effects on the body, therefore applying to several medications within a class.
Medications with boxed warnings associated with them may suffer financially as these warnings can affect the marketability of the drug and generate negative news reports.
Physicians must use their clinical judgment on whether or to prescribe not medications with these warnings to their patients care. Boxed warnings are not meant to be absolute contraindications for drugs, but instead, to bring the attention to the clinician and pharmacist on potential severe side effects.
In rare instances, a drug may be the subject of a recall from the market. The most serious type of recall (Class I) is when the use of a medication may cause severe health detriments or even possible death.
Examples of medications with warnings that have been updated
The Food and Drug Administration uses a program, i.e., MedWatch, that helps to track adverse events associated with medications. There is an online program accessible to clinicians and patients to enter complications with a medicine.
We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.
This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.
Click Your Answer Below
Would you like to access teaching points and more information on this topic?
|Buckley NA,Rossi S, Bringing greater transparency to [PubMed]|
|Panagiotou OA,Contopoulos-Ioannidis DG,Papanikolaou PN,Ntzani EE,Ioannidis JP, Different black box warning labeling for same-class drugs. Journal of general internal medicine. 2011 Jun; [PubMed]|
|O'Connor NR, FDA boxed warnings: how to prescribe drugs safely. American family physician. 2010 Feb 1; [PubMed]|
|Martin CM,Borgelt L, Black box warnings: what do they mean to pharmacists and patients. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. 2012 Jul; [PubMed]|
|Tanne JH, FDA adds [PubMed]|
|Tanne JH, FDA places [PubMed]|
|Kondro W, FDA urges [PubMed]|
|Lenzer J, FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke. BMJ (Clinical research ed.). 2005 Feb 26; [PubMed]|
|Green W, The FDA, contraceptive marketing approval and products liability litigation: Depo-Provera and the risk of osteoporosis. Food and drug law journal. 2013; [PubMed]|
|Mohammadi D, Black-box warnings could be removed from varenicline. The Lancet. Respiratory medicine. 2016 Nov; [PubMed]|
The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Optometry-Basic Science. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.
StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Optometry-Basic Science, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Optometry-Basic Science, you will already be prepared.
Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Optometry-Basic Science. When it is time for the Optometry-Basic Science board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Optometry-Basic Science.